Apollo Medical (AMEH) Stock Rating Upgraded by Zacks Investment Research

Share on StockTwits

Apollo Medical (OTCMKTS:AMEH) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued on Tuesday.

According to Zacks, “Apollo Medical Holdings, Inc. engages in the provision of healthcare services. It offers integrated care, inpatient and physician alignment solutions. The company focuses on physicians providing high-quality medical care, population health management and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. Apollo Medical Holdings, Inc. is headquartered in Glendale, CA. “

Shares of AMEH traded up $0.50 during midday trading on Tuesday, hitting $18.59. 35,386 shares of the stock were exchanged, compared to its average volume of 84,282. Apollo Medical has a 52-week low of $5.50 and a 52-week high of $30.00.

Apollo Medical (OTCMKTS:AMEH) last released its quarterly earnings results on Tuesday, August 14th. The healthcare company reported $0.07 EPS for the quarter, missing the consensus estimate of $0.10 by ($0.03). The firm had revenue of $123.01 million during the quarter.

In related news, CEO Warren Hosseinion sold 22,000 shares of Apollo Medical stock in a transaction on Monday, August 20th. The stock was sold at an average price of $18.10, for a total value of $398,200.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Adrian Vazquez sold 33,574 shares of Apollo Medical stock in a transaction on Monday, September 10th. The shares were sold at an average price of $15.25, for a total value of $512,003.50. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 196,474 shares of company stock valued at $3,249,480.

A number of large investors have recently added to or reduced their stakes in AMEH. BlackRock Inc. purchased a new position in Apollo Medical in the second quarter valued at $28,267,000. Millennium Management LLC boosted its holdings in Apollo Medical by 1,043.1% in the first quarter. Millennium Management LLC now owns 330,797 shares of the healthcare company’s stock valued at $5,276,000 after purchasing an additional 301,859 shares during the period. Northern Trust Corp purchased a new position in Apollo Medical in the second quarter valued at $6,137,000. Bank of New York Mellon Corp purchased a new position in Apollo Medical in the second quarter valued at $1,589,000. Finally, Schwab Charles Investment Management Inc. purchased a new position in Apollo Medical in the second quarter valued at $1,195,000.

Apollo Medical Company Profile

Apollo Medical Holdings, Inc is a patient-centered, physician-centric integrated population health management company working to provide coordinated, outcomes-based medical care. The Company operates in healthcare delivery segment. Its operations include Hospitalists, which include its contracted physicians focusing on the delivery of medical care to hospitalized patients; an accountable care organization (ACO), which focuses on providing care to Medicare fee-for-service patients; an independent practice association (IPA), which contracts with physicians and provides care to Medicare, Medicaid, commercial and dual-eligible patients on a risk- and value-based fee basis; approximately three clinics, which it owns or operates, and which provide specialty care in the greater Los Angeles area, and Palliative care, home health and hospice services, which include its at-home and end-of-life services.

Read More: Market Capitalization in the Stock Market

Get a free copy of the Zacks research report on Apollo Medical (AMEH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Apollo Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apollo Medical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply